# Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

> **NCT02113423** · NA · COMPLETED · sponsor: **Fujian Cancer Hospital** · enrollment: 168 (actual)

## Conditions studied

- Nasopharyngeal Cancer Recurrent

## Interventions

- **RADIATION:** 3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT

## Key facts

- **NCT ID:** NCT02113423
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** 2009-06
- **Final completion:** 2011-03
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2014-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02113423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02113423, "Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02113423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*